1. Home
  2. RGEN vs FND Comparison

RGEN vs FND Comparison

Compare RGEN & FND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • FND
  • Stock Information
  • Founded
  • RGEN 1981
  • FND 2000
  • Country
  • RGEN United States
  • FND United States
  • Employees
  • RGEN N/A
  • FND N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • FND RETAIL: Building Materials
  • Sector
  • RGEN Health Care
  • FND Consumer Discretionary
  • Exchange
  • RGEN Nasdaq
  • FND Nasdaq
  • Market Cap
  • RGEN 8.0B
  • FND 7.9B
  • IPO Year
  • RGEN N/A
  • FND 2017
  • Fundamental
  • Price
  • RGEN $126.50
  • FND $79.54
  • Analyst Decision
  • RGEN Buy
  • FND Hold
  • Analyst Count
  • RGEN 12
  • FND 19
  • Target Price
  • RGEN $172.67
  • FND $94.68
  • AVG Volume (30 Days)
  • RGEN 815.5K
  • FND 2.6M
  • Earning Date
  • RGEN 04-29-2025
  • FND 05-01-2025
  • Dividend Yield
  • RGEN N/A
  • FND N/A
  • EPS Growth
  • RGEN N/A
  • FND N/A
  • EPS
  • RGEN N/A
  • FND 1.89
  • Revenue
  • RGEN $650,429,000.00
  • FND $4,519,221,000.00
  • Revenue This Year
  • RGEN $13.93
  • FND $7.59
  • Revenue Next Year
  • RGEN $14.35
  • FND $10.93
  • P/E Ratio
  • RGEN N/A
  • FND $42.02
  • Revenue Growth
  • RGEN 4.88
  • FND 2.96
  • 52 Week Low
  • RGEN $102.97
  • FND $66.01
  • 52 Week High
  • RGEN $182.52
  • FND $126.74
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 44.61
  • FND 56.15
  • Support Level
  • RGEN $123.10
  • FND $72.78
  • Resistance Level
  • RGEN $135.47
  • FND $86.23
  • Average True Range (ATR)
  • RGEN 6.98
  • FND 2.62
  • MACD
  • RGEN -0.97
  • FND 1.18
  • Stochastic Oscillator
  • RGEN 25.20
  • FND 57.69

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About FND Floor & Decor Holdings Inc.

Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site.

Share on Social Networks: